Meridian Bioscience | VIVO - Equity Capital And Reserves

Meridian Bioscience reported $368.06M in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US USD -9988000 51.98M
Atrion ATRI:US USD 239.54M 6.91M
Becton, Dickinson and BDX:US USD 25.47B 190M
Bio Rad Laboratories BIO:US USD 9.62B 1.16B
Cerus CERS:US USD 67.61M 5.51M
Myriad Genetics MYGN:US USD 885.8M 30.8M
Neogen NEOG:US USD 3.11B 2.22B
Orasure Technologies OSUR:US USD 363.62M 21.73M
Quidel QDEL:US USD 4.93B 139.3M
Rockwell Medical RMTI:US USD 16.14M 4.01M
Sientra SIEN:US USD -4331000 13M
Staar Surgical STAA:US USD 332.19M 12.06M
Thermo Fisher Scientific TMO:US USD 44.03B 483M
Utah Medical Products UTMD:US USD 108.19M 715K